Biggest News Aggregation in the World
📰 Emerging Pathogens Program News

Page 2 - Emerging Pathogens Program News Today

Fast, Ad-Free News Updates

Stay updated with breaking news from Emerging Pathogens Program. Real-time updates on events, politics, business and more.

Independent Task Force report outlines a One Health approach to address risk factors for future pandemics

The Independent Task Force on COVID-19 and other Pandemics (www.independentcovidtaskforce.org) announced that their report "Pandemic Origins and a One Health Approach to Preparedness and Prevention: Solutions Based on SARS-CoV-2 and Other RNA Viruses" has been published in the Proceedings of the National Academy of Sciences.
New York United States Hong Kong Ohio State University Boston University University Of Hong Kong

Ohio State University: Flu causes cardiac complications by directly infecting the heart

Researchers have shown for the first time in mice that heart problems associated with the flu are not caused by raging inflammation in the lungs, as has long been predicted.Instead, the Ohio State University study revealed, the electrical malfunction
United States Ohio State University Jacob Yount Ohio State Infectious Diseases Institute Ohio State College Of Medicine Pathogens Program

Ohio State University: Booster critical as COVID-19 vaccine-induced antibodies wane in 6 months, don't protect against omicron – India Education | Latest Education News | Global Educational News

A new study using serum from human blood samples suggests neutralizing antibody levels produced by two-dose mRNA vaccines against the original and early variants of the SARS-CoV-2 virus wane substantially over time, and offer essentially no protectio
United States Ohio State University John Evans Shan Lu Liu Developmental Biology Program Ohio State Infectious Diseases Institute

Stay Updated with Latest News

Get breaking news updates delivered to your inbox

Browse All News →

Study finds booster shot did produce effective levels of neutralizing antibodies against omicron

A new study using serum from human blood samples suggests neutralizing antibody levels produced by two-dose mRNA vaccines against the original and early variants of the SARS-CoV-2 virus wane substantially over time, and offer essentially no protection against the omicron variant.
United States Ohio State University John Evans Shan Lu Liu Emily Henderson Department Of Veterinary Biosciences

Explore More Categories

World News India News Business Technology Sports Entertainment Health Science